Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-19

FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)

View source ↗

Summary

FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)